1020例开放胸降主动脉及胸腹主动脉瘤修复的长期临床结局
该研究回顾性分析1997至2023年单中心1020例开放胸降主动脉瘤(DTA)和胸腹主动脉瘤(TAAA)修复患者,按瘤体范围分层。总体手术死亡率4.6%,DTA组5.1%,TAAA组4.4%。中位随访6.72年,DTA组5年和10年生存率分别为67.2%和48.2%,TAAA组分别为69.9%和47.5%。
要点
- 开放DTA/TAAA修复在高容量中心手术死亡率为4.6%,截瘫率1.3%。
- 糖尿病和肾功能不全是手术死亡的独立危险因素。
- TAAA中Extent II动脉瘤与手术死亡独立相关。
核心结论
- 在有经验的中心,开放DTA/TAAA修复的手术结局和长期生存令人鼓舞。
- 短期结局取决于术前危险因素和动脉瘤范围,长期生存取决于年龄和慢性合并症。
研究设计与样本
- 回顾性队列研究,纳入1997年至2023年连续接受DTA/TAAA开放修复的1020例患者。
- 按动脉瘤范围分层:DTA 273例,TAAA 747例(Extent I 53.1%,II 18.5%,III 20.2%,IV 7.6%,V 5%)。
主要发现
- 总体手术死亡率为4.6%,DTA组5.1%,TAAA组4.4%。
- 心肌梗死发生率0.5%,卒中1.8%,气管切开6.9%,透析4.8%,截瘫1.3%。
- 中位随访6.72年(95%CI 5.73-7.81),DTA组5年和10年生存率分别为67.2%和48.2%,TAAA组分别为69.9%和47.5%。
临床怎么用
- 对于DTA/TAAA患者,开放修复可在高容量中心取得可接受的围术期和长期结果。
- 术前应评估糖尿病、肾功能不全等危险因素,尤其TAAA Extent II患者手术风险更高。
- 长期随访应关注年龄、COPD、糖尿病、肾功能不全等合并症对生存的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess long-term survival and operative outcomes of open descending thoracic aneurysm (DTA) and thoracoabdominal aortic aneurysm (TAAA) repair at a high-volume center. METHODS: We identified all consecutive patients undergoing DTA/TAAA repair between 1997 and 2023 and stratified based on aneurysm extent. Operative outcomes were assessed by univariable and multivariable analysis. Long-term survival was estimated by Kaplan-Meier method. RESULTS: Of 1020 patients, 273 had DTA and 747 had TAAA (53.1% extent I, 18.5% extent II, 20.2% extent III, 7.6% extent IV, and 5% extent V). Operative mortality (OM) was 4.6% overall, 5.1% in the DTA group, and 4.4% in the TAAA group. The incidence of myocardial infarction was 0.5%; stroke, 1.8%; tracheostomy, 6.9%; dialysis, 4.8%; and paraplegia, 1.3%. On multivariable analysis, diabetes (odds ratio [OR], 2.48; 95% confidence interval [CI], 1.20-5.13; P = .014) and renal insufficiency (OR, 3.17; 95% CI, 1.63-6.13; P < .001) were associated with OM. In the TAAA group, extent II aneurysm (OR, 3.56; 95% CI, 1.59-7.96; P = .002) was associated with OM. The median follow-up was 6.72 (95% CI, 5.73-7.81) years. Five- and 10-year survival were 67.2% and 48.2% for the DTA group and 69.9% and 47.5% for the TAAA group. In the TAAA group, 5- and 10-year survival were 76.4% and 49.4% for extent I, 62.5% and 43.3% for extent II, 60.1% and 45.6% for extent III, and 72.6% and 47.4% for extent IV. Age (hazard ratio [HR], 1.04; 95% CI, 1.02-1.05; P < .001), chronic obstructive pulmonary disease (HR, 1.55; 95% CI, 1.25-1.92; P < .001), diabetes (HR, 1.5; 95% CI, 1.09-2.07; P = .013), renal insufficiency (HR, 1.47; 95% CI, 1.18-1.85; P < .001), shock (HR, 1.83; 95% CI, 1.19-2.81; P = .006), and urgent/emergent surgery (HR, 1.27; 95% CI, 1.03-1.58; P = .027) were associated with long-term mortality. CONCLUSIONS: At experienced centers, operative outcomes and long-term survival after open DTA/TAAA repair are encouraging. Short-term outcomes are dependent on preoperative risk factors and aneurysm extent, while long-term survival is dependent on age and chronic comorbidities.
引用
- Lau C, Ram E, Harik L, et al. Long-term clinical outcomes of 1020 open repairs of descending thoracic and thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg. 2025. PMID: 41072895. doi:10.1016/j.jtcvs.2025.09.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。